Patents by Inventor Kyeong-Han PARK

Kyeong-Han PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microphthalmia-associated transcription factor-derived peptide and composition containing same
    Patent number: 9493528
    Abstract: Provided are small peptide fragments derived from microphthalmia-associated transcription factor (MITF) and a method for preventing or treating melanoma using the same as an active ingredient. Further provided is a method for skin-whitening and/or for inhibiting skin pigmentation, using the peptide fragments as an active ingredient.
    Type: Grant
    Filed: January 7, 2014
    Date of Patent: November 15, 2016
    Assignees: SUPADELIXIR INC., KNU-INDUSTRY COOPERATION FOUNDATION
    Inventors: Kyeong-Han Park, Jang-Hee Hahn, Dong-Young Lim
  • MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR-DERIVED PEPTIDE AND COMPOSITION CONTAINING SAME
    Publication number: 20160002308
    Abstract: The present invention provides small peptide fragments derived from microphthalmia-associated transcription factor (MITF) and a pharmaceutical composition for preventing or treating melanoma comprising the same as an active ingredient. And also, the present invention provides a cosmetic composition for skin-whitening and/or for inhibiting skin pigmentation, comprising the peptide fragments as an active ingredient.
    Type: Application
    Filed: January 7, 2014
    Publication date: January 7, 2016
    Applicants: SUPADELIXIR INC., KNU-INDUSTRY COOPERATION FOUNDATION
    Inventors: Kyeong-Han PARK, Jang-Hee HAHN, Dong-Young LIM